| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | 0.24 | 2e-11 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | 0.34 | 4e-11 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | 0.36 | 4e-11 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | 0.33 | 4e-11 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.24 | 3e-10 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | 0.25 | 4e-10 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | 0.21 | 4e-10 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.21 | 8e-10 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | 0.21 | 8e-10 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.2 | 2e-09 |